Sergio Arredondo-Alonso1,2, Janetta Top1, Jukka Corander2,3,4, Rob J L Willems1, Anita C Schürch5. 1. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Biostatistics, University of Oslo, Oslo, Norway. 3. Pathogen Genomics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK. 4. Department of Mathematics and Statistics, Helsinki Institute of Information Technology (HIIT), FI-00014 University of Helsinki, Helsinki, Finland. 5. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. a.c.schurch@umcutrecht.nl.
Abstract
BACKGROUND: Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be conferred by the vanA gene cluster on the transposon Tn1546, which is frequently present in plasmids. The vanA gene cluster can be disseminated clonally but also horizontally either by plasmid dissemination or by Tn1546 transposition between different genomic locations. METHODS: We performed a retrospective study of the genomic epidemiology of 309 vancomycin-resistant E. faecium (VRE) isolates across 32 Dutch hospitals (2012-2015). Genomic information regarding clonality and Tn1546 characterization was extracted using hierBAPS sequence clusters (SC) and TETyper, respectively. Plasmids were predicted using gplas in combination with a network approach based on shared k-mer content. Next, we conducted a pairwise comparison between isolates sharing a potential epidemiological link to elucidate whether clonal, plasmid, or Tn1546 spread accounted for vanA-type resistance dissemination. RESULTS: On average, we estimated that 59% of VRE cases with a potential epidemiological link were unrelated which was defined as VRE pairs with a distinct Tn1546 variant. Clonal dissemination accounted for 32% cases in which the same SC and Tn1546 variants were identified. Horizontal plasmid dissemination accounted for 7% of VRE cases, in which we observed VRE pairs belonging to a distinct SC but carrying an identical plasmid and Tn1546 variant. In 2% of cases, we observed the same Tn1546 variant in distinct SC and plasmid types which could be explained by mixed and consecutive events of clonal and plasmid dissemination. CONCLUSIONS: In related VRE cases, the dissemination of the vanA gene cluster in Dutch hospitals between 2012 and 2015 was dominated by clonal spread. However, we also identified outbreak settings with high frequencies of plasmid dissemination in which the spread of resistance was mainly driven by horizontal gene transfer (HGT). This study demonstrates the feasibility of distinguishing between modes of dissemination with short-read data and provides a novel assessment to estimate the relative contribution of nested genomic elements in the dissemination of vanA-type resistance.
BACKGROUND: Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be conferred by the vanA gene cluster on the transposon Tn1546, which is frequently present in plasmids. The vanA gene cluster can be disseminated clonally but also horizontally either by plasmid dissemination or by Tn1546 transposition between different genomic locations. METHODS: We performed a retrospective study of the genomic epidemiology of 309 vancomycin-resistant E. faecium (VRE) isolates across 32 Dutch hospitals (2012-2015). Genomic information regarding clonality and Tn1546 characterization was extracted using hierBAPS sequence clusters (SC) and TETyper, respectively. Plasmids were predicted using gplas in combination with a network approach based on shared k-mer content. Next, we conducted a pairwise comparison between isolates sharing a potential epidemiological link to elucidate whether clonal, plasmid, or Tn1546 spread accounted for vanA-type resistance dissemination. RESULTS: On average, we estimated that 59% of VRE cases with a potential epidemiological link were unrelated which was defined as VRE pairs with a distinct Tn1546 variant. Clonal dissemination accounted for 32% cases in which the same SC and Tn1546 variants were identified. Horizontal plasmid dissemination accounted for 7% of VRE cases, in which we observed VRE pairs belonging to a distinct SC but carrying an identical plasmid and Tn1546 variant. In 2% of cases, we observed the same Tn1546 variant in distinct SC and plasmid types which could be explained by mixed and consecutive events of clonal and plasmid dissemination. CONCLUSIONS: In related VRE cases, the dissemination of the vanA gene cluster in Dutch hospitals between 2012 and 2015 was dominated by clonal spread. However, we also identified outbreak settings with high frequencies of plasmid dissemination in which the spread of resistance was mainly driven by horizontal gene transfer (HGT). This study demonstrates the feasibility of distinguishing between modes of dissemination with short-read data and provides a novel assessment to estimate the relative contribution of nested genomic elements in the dissemination of vanA-type resistance.
Authors: Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner Journal: J Comput Biol Date: 2012-04-16 Impact factor: 1.479
Authors: Guido Werner; Ana R Freitas; Teresa M Coque; Johanna E Sollid; Camilla Lester; Anette M Hammerum; Lourdes Garcia-Migura; Lars B Jensen; Maria V Francia; Wolfgang Witte; R J Willems; Arnfinn Sundsfjord Journal: J Antimicrob Chemother Date: 2010-12-03 Impact factor: 5.790
Authors: Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen Journal: J Antimicrob Chemother Date: 2012-07-10 Impact factor: 5.790
Authors: Anna E Sheppard; Nicole Stoesser; Ian German-Mesner; Kasi Vegesana; A Sarah Walker; Derrick W Crook; Amy J Mathers Journal: Microb Genom Date: 2018-11-22
Authors: Ana R Freitas; Carla Novais; Ana P Tedim; María Victoria Francia; Fernando Baquero; Luísa Peixe; Teresa M Coque Journal: PLoS One Date: 2013-03-29 Impact factor: 3.240
Authors: Mathilde Boumasmoud; Vanina Dengler Haunreiter; Tiziano A Schweizer; Lilly Meyer; Bhavya Chakrakodi; Peter W Schreiber; Kati Seidl; Denise Kühnert; Roger D Kouyos; Annelies S Zinkernagel Journal: mBio Date: 2022-03-28 Impact factor: 7.786
Authors: Ilona Trautmannsberger; Laura Kolberg; Melanie Meyer-Buehn; Johannes Huebner; Guido Werner; Robert Weber; Valerie Heselich; Sebastian Schroepf; Hans-Georg Muench; Ulrich von Both Journal: Antimicrob Resist Infect Control Date: 2022-03-12 Impact factor: 4.887